Orchestra Biomed Hldgs Inc (OBIO) Stock Price, Quote & News

Company Profile

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications,...

Industry: Biotechnology

Sector: Healthcare

Phone: 215 862 5797

Website: www.orchestrabiomed.com

Address:

150 Union Square Drive, New Hope, United States

FilingTracker Sep. 8 at 12:16 PM

$OBIO CEO purchase: https://filingtracker.ai/filing/1292834/0001104659-26-105690?doc=tm2624891-1_4seq1.xml

0 · Reply

Carl2233 Sep. 7 at 4:41 PM

$OBIO gut tells me we will be in the 20s by year end as crazy stupid as that sounds. There business model is so unique and powerful. This is under the radar.

1 · Reply

Planktont Sep. 5 at 12:45 AM

$OBIO Phase 2a data expected in 2026, major catalyst…

0 · Reply

Carl2233 Sep. 3 at 4:44 PM

$OBIO I like this company because of there unique business model, as the street starts to learn this is going to 20x IMO

0 · Reply

layLOW120 Aug. 24 at 8:53 PM

$VBIO higher highs and higher lows.....See you all tomorrow $ORMP $IMUX $CURR $OBIO going next swingy swing

0 · Reply

layLOW120 Aug. 21 at 7:56 AM

$OBIO There is a breakout on the daily at 7.30...... Next move to 8 quick....... Need to break 5.80 to 6.50 then game on boys!!!!

0 · Reply

Jordan3333 Aug. 20 at 2:04 PM

$OBIO going up lately on nice volume, going towards the end of September when the company should announce the end of the recruitment. At that point the stock should have a very nice move up and the home run will be at the April conference, when Medtronic and obio will share the fantastic significant results, and the grand slam when sales start at the beginning of 2027.

0 · Reply

Carl2233 Aug. 19 at 4:52 PM

$OBIO might double over night soon.

0 · Reply

player5157 Aug. 18 at 8:17 PM

$OBIO i'm glad I loaded up at 3.75

0 · Reply

BinaryLogic Aug. 18 at 7:59 PM

$OBIO $MDT [Again]

1 · Reply

Orchestra BioMed upgraded to Buy from Neutral at BTIG

Sep 2, 2026, 4:05 PM EDT - 7 days ago

Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aug 27, 2026, 8:30 AM EDT - 14 days ago

Orchestra BioMed to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Aug 20, 2026, 8:30 AM EDT - 21 days ago

Orchestra BioMed to Participate in the Wells Fargo 21st Annual Healthcare Conference

2026-08-11T11:00:55.000Z - 4 weeks ago

Orchestra BioMed price target raised to $10 from $9 at Piper Sandler

2026-08-10T21:20:24.000Z - 4 weeks ago

Orchestra BioMed reports Q2 EPS (37c), consensus (38c)

Aug 10, 2026, 7:00 AM EDT - 4 weeks ago

Orchestra BioMed Holdings Quarterly report: Q2 2026

Aug 10, 2026, 7:00 AM EDT - 4 weeks ago

Orchestra BioMed Holdings Earnings release: Q2 2026

2026-06-29T12:16:49.000Z - 2 months ago

Orchestra BioMed joins Russell 3000, Russell 2000 Indexes

Jun 29, 2026, 8:00 AM EDT - 2 months ago

Orchestra BioMed Joins Russell 3000® and Russell 2000® Indexes

Jun 23, 2026, 12:00 PM EDT - 2 months ago

Orchestra BioMed Holdings Transcript: AGM 2026

Jun 18, 2026, 1:00 PM EDT - 2 months ago

Orchestra BioMed Holdings Transcript: Sidoti Small-Cap Virtual Investor Conference

Jun 16, 2026, 8:00 AM EDT - 2 months ago

Orchestra BioMed Holdings Proxy statement: Proxy filing

Jun 4, 2026, 9:55 AM EDT - 3 months ago

Orchestra BioMed Holdings Transcript: Jefferies Global Healthcare Conference 2026

Jun 4, 2026, 7:00 AM EDT - 3 months ago

Orchestra BioMed Holdings Slides: Corporate presentation

2026-05-19T12:40:53.000Z - 3 months ago

Orchestra BioMed price target lowered to $10 from $12 at B. Riley

May 19, 2026, 8:30 AM EDT - 3 months ago

Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference

2026-05-13T09:15:10.000Z - 4 months ago

Orchestra BioMed price target raised to $13 from $12 at Barclays

2026-05-12T21:08:53.000Z - 4 months ago

Orchestra BioMed reports Q1 EPS (33c), consensus (44c)

May 12, 2026, 4:18 PM EDT - 4 months ago

Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates

2026-05-12T14:08:39.000Z - 4 months ago

Orchestra BioMed gives clinical, regulatory update on BACKBEAT trial timeline

MDT

May 12, 2026, 8:30 AM EDT - 4 months ago

Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027

May 12, 2026, 7:00 AM EDT - 4 months ago

Orchestra BioMed Holdings Quarterly report: Q1 2026

May 12, 2026, 7:00 AM EDT - 4 months ago

Orchestra BioMed Holdings Earnings release: Q1 2026

2026-05-07T05:00:15.000Z - 4 months ago

Orchestra BioMed receives $15M payment from Ligand

LGND

May 6, 2026, 8:01 AM EDT - 4 months ago

Orchestra BioMed Receives $15 Million Investment from Ligand Under Previously Announced Strategic Financing Agreement

May 6, 2026, 8:00 AM EDT - 4 months ago

Orchestra BioMed Receives $20 Million Payment from Medtronic Under Previously Announced Financing Agreement

MDT

2026-04-30T19:15:18.000Z - 4 months ago

Orchestra granted additional breakthrough device designation for AVIM therapy

MDT

Apr 30, 2026, 9:00 AM EDT - 4 months ago

FDA Grants Orchestra BioMed Additional Breakthrough Device Designation for AVIM Therapy

MDT

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Orchestra BioMed Holdings Proxy statement: Proxy filing

Apr 29, 2026, 8:00 AM EDT - 4 months ago

Orchestra BioMed Holdings Proxy statement: Proxy filing

Apr 23, 2026, 12:00 PM EDT - 4 months ago

Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

Apr 1, 2026, 7:00 AM EDT - 5 months ago

Orchestra BioMed Holdings Slides: Corporate presentation

2026-03-12T12:28:04.000Z - 6 months ago

Orchestra BioMed reports FY25 EPS ($1.11), consensus ($1.74)

Mar 12, 2026, 8:17 AM EDT - 6 months ago

Orchestra BioMed Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update

Mar 12, 2026, 7:00 AM EDT - 6 months ago

Orchestra BioMed Holdings Earnings release: Q4 2025

Mar 12, 2026, 7:00 AM EDT - 6 months ago

Orchestra BioMed Holdings Annual report: Q4 2025

Mar 11, 2026, 8:00 AM EDT - 6 months ago

Orchestra BioMed Holdings Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 3, 2026, 9:50 AM EST - 6 months ago

Orchestra BioMed Holdings Transcript: TD Cowen 46th Annual Health Care Conference

2026-03-03T13:22:43.000Z - 6 months ago

Orchestra BioMed announces two presentations at THT, CRT 2026 meetings

Mar 3, 2026, 8:00 AM EST - 6 months ago

Orchestra BioMed Announces Presentations Highlighting AVIM Therapy Potential Impact on Hypertensive Heart Disease and Heart Failure at THT and CRT

Feb 19, 2026, 8:00 AM EST - 6 months ago

Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences

Feb 18, 2026, 7:00 AM EST - 6 months ago

Orchestra BioMed Holdings Slides: Corporate presentation

2026-01-12T14:11:12.000Z - 8 months ago

Orchestra BioMed to receive up to $21M in proceeds from Vivasure acquisition

HAE

Jan 12, 2026, 9:00 AM EST - 8 months ago

Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics

HAE

2026-01-09T12:25:37.000Z - 8 months ago

Orchestra BioMed price target raised to $12 from $11 at Barclays

2025-12-10T11:05:22.000Z - 9 months ago

Orchestra BioMed initiated with a Buy at TD Cowen

Dec 8, 2025, 7:00 AM EST - 9 months ago

Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting

Dec 3, 2025, 11:00 AM EST - 9 months ago

Orchestra BioMed Holdings Transcript: Piper Sandler 37th Annual Healthcare Conference

Nov 12, 2025, 8:00 AM EST - 10 months ago

Orchestra BioMed Holdings Transcript: Status Update

FilingTracker Sep. 8 at 12:16 PM

$OBIO CEO purchase: https://filingtracker.ai/filing/1292834/0001104659-26-105690?doc=tm2624891-1_4seq1.xml

0 · Reply

Carl2233 Sep. 7 at 4:41 PM

$OBIO gut tells me we will be in the 20s by year end as crazy stupid as that sounds. There business model is so unique and powerful. This is under the radar.

1 · Reply

Planktont Sep. 5 at 12:45 AM

$OBIO Phase 2a data expected in 2026, major catalyst…

0 · Reply

Carl2233 Sep. 3 at 4:44 PM

$OBIO I like this company because of there unique business model, as the street starts to learn this is going to 20x IMO

0 · Reply

layLOW120 Aug. 24 at 8:53 PM

$VBIO higher highs and higher lows.....See you all tomorrow $ORMP $IMUX $CURR $OBIO going next swingy swing

0 · Reply

layLOW120 Aug. 21 at 7:56 AM

$OBIO There is a breakout on the daily at 7.30...... Next move to 8 quick....... Need to break 5.80 to 6.50 then game on boys!!!!

0 · Reply

Jordan3333 Aug. 20 at 2:04 PM

0 · Reply

Carl2233 Aug. 19 at 4:52 PM

$OBIO might double over night soon.

0 · Reply

player5157 Aug. 18 at 8:17 PM

$OBIO i'm glad I loaded up at 3.75

0 · Reply

BinaryLogic Aug. 18 at 7:59 PM

$OBIO $MDT [Again]

1 · Reply

layLOW120 Aug. 18 at 5:16 PM

$OBIO what did I say? Tested at 5.44..... Now break 5.44 with strength..... Boom Boom

1 · Reply

JHisai Aug. 18 at 3:49 PM

$OBIO cha-ching

0 · Reply

layLOW120 Aug. 17 at 11:15 PM

$OBIO has multiple breakouts from a technical standpoint. We break 5 next leg to 5.42 and then it's going to get weird right to 6.

0 · Reply

JHisai Aug. 13 at 12:37 PM

EVO US30050E1055, first target $3, will take a while, earnigs meh+trust issues, $OBIO $ALLO nice moves again

0 · Reply

Carl2233 Aug. 12 at 4:20 PM

$OBIO Building a long position. Slow N steady, I like this dips.

0 · Reply

Starlord10 Aug. 6 at 5:45 AM

$OBIO good earnings vibe! 🍀🍺

0 · Reply

JHisai Aug. 5 at 8:01 AM

$OBIO $4.3 MOB

0 · Reply

Jordan3333 Aug. 4 at 7:57 AM

$OBIO it seems like we finally hit the bottom. I believe that the quarterly earnings with the release will give better clarity and the stock should do better and when the recruitment is finished, hopefully before the end of September, then we should be. Trading between 6-8

0 · Reply

Pkinla Jul. 22 at 6:18 PM

$OBIO can someone post the SA article by Roudasev today!?

0 · Reply

Starlord10 Jul. 9 at 4:47 PM

$OBIO Looking to buy back in. Trade the $3.8 to $4.1 range again?

0 · Reply

TigrePeidando Jul. 9 at 3:14 AM

$OBIO Fart on this stock

0 · Reply

JHisai Jul. 1 at 10:10 AM

$OBIO monthly

0 · Reply

Market Cap	326.37M
Revenue (ttm)	33.48M
Net Income (ttm)	-52.70M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-157.41%
Debt to Equity Ratio	1.80

Volume	198,500
Avg Vol	268,608
Day's Range	N/A - N/A
Shares Out	60.11M
Stochastic %K	93%
Beta	0.54
Analysts	Strong Sell
Price Target	$12.83